MENU
CDXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Codexis (CDXS) Ownership - Who owns Codexis?
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes... Show more
Industry: #Chemicals Specialty
Profile
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
206.26M
P/E Ratio
N/A
Total Cash
73.46M
Projected Growth
N/A
Total Debt
59.9M
Revenue
59.35M
Risk (Beta)
2.37
Dividend Yield
N/A
Total Cash/Share
0.89
Total Debt/Equity
N/A
Revenue/Share
0.81 USD as % of share price
Fundamentals
CDXS
Capitalization
206M
P/E Ratio
N/A
Risk (Beta)
2.37
Dividend Yield
N/A
Total Cash
73.5M
Total Cash/Share
0.89
Total Debt
59.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.81%
Revenue
59.3M
ROE
N/A
Book Value
66.9M
P/B Ratio
3.08
Cash Flow
N/A
Earnings
-0.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
4.18
Current Revenue Per Employee
114148.94
Dividends Per Share - Security
N/A
EBITDA
-53.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.97
Revenue To Assets
-45.72
Shares Held By Institutions
437M
Shares Outstanding - Current
82.8M
Total Liabilities
82.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-47.799
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biocatalytic chemical processes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
200 Penobscot Drive
Phone
+1 650 421-8100
Employees
174
Web
https://www.codexis.com